A Molina

524 citations

19 papers · 330 indexed · h-index 8

Impact in

Hematology top 5%
- Hematopoietic Stem Cell Transplantation
- Chronic Myeloid Leukemia Treatments
- Acute Myeloid Leukemia Research
Pathology and Forensic Medicine
- Lymphoma Diagnosis and Treatment

Papers in

Hematology 8
- Hematopoietic Stem Cell Transplantation 8
- Chronic Myeloid Leukemia Treatments 2
Applied Microbiology and Biotechnology 1

Co-authors: DS Snyder PM Parker Andrew Dagis Irena Sniecinski Anthony S. Stein EP Smith GM Schmidt Auayporn Nademanee
Journals: Blood (4 papers)Journal of Clinical Oncology (3 papers)Postgraduate Medical Journal (2 papers)Bone Marrow Transplantation (1 paper)Histopathology (1 paper)
Partner nations: United States Spain Germany

In The Last Decade

A Molina

18 papers receiving 316 citations

Peers

Countries citing papers authored by A Molina

Since Specialization

Citations

This map shows the geographic impact of A Molina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Molina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Molina more than expected).

Fields of papers citing papers by A Molina

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Molina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Molina. The network helps show where A Molina may publish in the future.

Co-authors

The 25 scholars most cited alongside A Molina, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with A Molina Line = papers co-authored together A Molina links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work
1	Characterization of hospitalized patients with acute kidney injury associated with COVID-19 in Spain: renal replacement therapy and mortality. FRA-COVID SEN Registry Data Nefrología (English Edition) ·Mercedes Salgueira, Marina Almenara, (unknown), Lara Belmar, Pedro Jesús Labrador, Rosa Melero, Trinidad Serrano, José Pórtoles, A Molina, Esteban Poch, Natália Ramos, María Jesús Lloret, Rocío Echarri, Raquel Díaz, D.M. González- Lara, J. Emilio Sanchez, María José Soler	2024	1
2	Coinfección y sobreinfección bacteriana en pacientes con neumonía por COVID-19 en el Nuevo Hospital San Roque de Córdoba (2020 A Molina, Verónica Muñoz, Cecilia Olocco, L Vacaflor, Nora Peralta, Natalia Gerván	2022	0
3	[Sclerosing encapsulating peritonitis: a latent threat. Changes of posture in surgery treatment]. PubMed ·J C Herrero, A Molina, Carolina Lentisco, Catherine M. Garcia, Milagros Ortiz, Carmen Mon, Olimpia Ortega, Isabel Rodrı́guez, Aniana Oliet, A. Vigil, Paloma Gallar	2007	5
4	Rearrangement of only one human IGHV gene is sufficient to generate a wide repertoire of antigen specific antibody responses in transgenic mice Molecular Immunology ·E. Suárez, Susana Magadán, I Sanjuán, M. Valladares, A Molina, Francisco Gambón, Fernando Díaz‐Espada, África González‐Fernández	2005	14
5	Low incidence of treatment-related myelodysplastic syndrome (tMDS) and acute myelogenous leukemia (tAML) in patients with non-Hodgkin's lymphoma (NHL) treated with ibritumomab tiuxetan Journal of Clinical Oncology ·C. Emmanouilides, M. S. Czuczman, S T REVELL, T. E. Witzig, H. Wang, Leo I. Gordon, B. Skikne, Paul Foster, A Molina	2004	1
6	The city of hope experience with novel transplant regimens that incorporate standard and escalated dose 90YTTRIUM ibritumomab tiuxetan (90Y-Zevalin®) radioimmunotherapy (RIT) for autologous stem cell transplantation (ASCT) in patients with B-cell non-Hodgkin’s lymphoma (NHL): targeted intensification without increased toxicity and elimination of total body irradiation (TBI) Biology of Blood and Marrow Transplantation ·Auayporn Nademanee, Henry C. Fung, A Molina, A. Krishnan, R. Rodriguez, Leslie Popplewell, Ricardo Spielberger, Maureen O’Donnell, D. Snyder, PM Parker, Anthony S. Stein, Neil Kogut, Peter Falk, Firoozeh Sahebi, Jasmine Zain, Wayne Saville, Andrew Raubitschek, Stephen J. Forman	2004	1
7	High-dose radioimmunotherapy with yttrium 90 (⁹⁰Y) ibritumomab tiuxetan with high-dose etoposide (VP-16) and cyclophosphamide (CY) followed by autologous hematopoietic cell transplant (AHCT) for poor-risk or relapsed B-cell non-Hodgkin's lymphoma (NHL): Update of a phase I/II trial Journal of Clinical Oncology ·AP Nademanee, Stephen J. Forman, A Molina, Neil Kogut, Henry C. Fung, Dave Yamauchi, Anne-Line Anderson, D. Lynne Smith, A. N. Liu, A. Raubitschek	2004	2
8	Radiation-free regimens result in similar outcomes of allogeneic hematopoietic progenitor cell transplantation in patients aged ≥50 years compared to younger adults with low-risk disease Bone Marrow Transplantation ·Sherif S. Farag, Patrick Elder, Guido Marcucci, Sam Penza, Ewa Mrózek, A Molina, Thomas S. Lin, Belinda R. Avalos, Edward A. Copelan	2003	9
9	Allogeneic hematopoietic stem cell transplantation: from the nuclear age into the twenty-first century Transplantation Proceedings ·Rainer Storb, PA McSweeney, Brenda M. Sandmaier, RA Nash, George E. Georges, David G. Maloney, A Molina, Thomas R. Chauncey, Cong Yu, Jan Maciej Zaucha, Karl G. Blume, Judith A. Shizuru, Dietger Niederwieser	2000	8
10	Nonmyeloablative conditioning for stem cell allografts with low-dose tbi Experimental Hematology ·BM Sandmaier, DG Maloney, Peter A. McSweeney, Dietger Niederwieser, Judith A. Shizuru, T Chauncey, Ted Gooley, A Molina, Jerald P. Radich, Karl G. Blume, Rainer Storb	2000	2
11	Long-term follow-up of 23 patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with allogeneic bone marrow transplant in first complete remission Leukemia ·DS Snyder, AP Nademanee, MR O’Donnell, PM Parker, AS Stein, Kim Margolin, George Somlo, A Molina, Ricardo Spielberger, A. Kashyap, Henry C. Fung, ML Slovak, Andrew Dagis, RS Negrin, MD Amylon, KG Blume, SJ Forman	1999	81
12	Effect of CD34+ Selection and Various Schedules of Stem Cell Reinfusion and Granulocyte Colony-Stimulating Factor Priming on Hematopoietic Recovery After High-Dose Chemotherapy for Breast Cancer Blood ·George Somlo, Irena Sniecinski, Tamara Odom‐Maryon, Barbara Nowicki, Warren Chow, Victor Hamasaki, L. Leong, Kim Margolin, R.J. Morgan, James Raschko, Stephen Shibata, Merry Tetef, A Molina, Ronald Berenson, Stephen J. Forman, J. H. Doroshow	1997	1
13	Effect of CD34+ Selection and Various Schedules of Stem Cell Reinfusion and Granulocyte Colony-Stimulating Factor Priming on Hematopoietic Recovery After High-Dose Chemotherapy for Breast Cancer Blood ·George Somlo, Irena Sniecinski, Tamara Odom‐Maryon, Barbara Nowicki, Warren Chow, Victor Hamasaki, L. Leong, Kim Margolin, R.J. Morgan, James Raschko, Stephen Shibata, Merry Tetef, A Molina, Ronald Berenson, Stephen J. Forman, J. H. Doroshow	1997	35
14	The outcome of matched unrelated donor bone marrow transplantation in patients with hematologic malignancies using molecular typing for donor selection and graft-versus-host disease prophylaxis regimen of cyclosporine, methotrexate, and prednisone Blood ·Auayporn Nademanee, GM Schmidt, Pablo Parker, AC Dagis, Anthony S. Stein, DS Snyder, M O’Donnell, EP Smith, DE Stepan, A Molina	1995	4
15	High-dose therapy followed by autologous peripheral-blood stem-cell transplantation for patients with Hodgkin's disease and non-Hodgkin's lymphoma using unprimed and granulocyte colony-stimulating factor-mobilized peripheral-blood stem cells. Journal of Clinical Oncology ·Auayporn Nademanee, Irena Sniecinski, GM Schmidt, Andrew Dagis, Margaret O’Donnell, DS Snyder, PM Parker, Anthony S. Stein, EP Smith, A Molina	1994	105
16	Signet‐ring cell lymphoma of T‐cell type with CD30 expression Histopathology ·C Bellas, A Molina, Carlos Montalbán, F Mampaso	1993	13
17	Detection of Epstein-Barr genome in the lymph nodes of Hodgkin's disease Postgraduate Medical Journal ·C Bellas, F Mampaso, G. Fraile, A Molina, T Bricio, C. Cuesta	1993	1
18	In situ demonstration of Epstein-Barr virus in intravenous drug abusers with generalized lymphadenopathy Postgraduate Medical Journal ·F Mampaso, C Bellas, A Molina, C. Quereda, T Bricio, Luís Buzón	1992	2
19	SUP-HD1: a new Hodgkin's disease-derived cell line with lymphoid features produces interferon-gamma [see comments] Blood ·Louie Naumovski, PJ Utz, SK Bergstrom, R Morgan, A Molina, JJ Toole, BE Glader, P McFall, Weiss Lm, R Warnke	1989	45

About A Molina

A Molina is a scholar working on Hematology, Applied Microbiology and Biotechnology, Pathology and Forensic Medicine, Nephrology and Infectious Diseases, having authored 19 papers that have together received 330 indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (8 papers), Lymphoma Diagnosis and Treatment (7 papers), Lung Cancer Treatments and Mutations (3 papers), Neutropenia and Cancer Infections (3 papers), Immune Cell Function and Interaction (3 papers), Radiopharmaceutical Chemistry and Applications (2 papers), Chronic Myeloid Leukemia Treatments (2 papers) and Parvovirus B19 Infection Studies (2 papers). The work is most often cited by research in Hematology (214 citations), Pathology and Forensic Medicine (80 citations), Oncology (120 citations), Genetics (45 citations) and Public Health, Environmental and Occupational Health (87 citations). A Molina has collaborated with scholars based in United States, Spain and Germany. Frequent co-authors include DS Snyder, PM Parker, Andrew Dagis, Irena Sniecinski, Anthony S. Stein, EP Smith, GM Schmidt, Auayporn Nademanee, Margaret O’Donnell and Kim Margolin. Their work appears in journals such as Blood, Journal of Clinical Oncology, Postgraduate Medical Journal, Bone Marrow Transplantation and Histopathology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact